CCH Pipeline

Indication
Preclinical
Phase 1
Phase 2
Phase 3
Marketed
Approved Indications
Dupuytren’s Contracture
Peyronie’s Disease
Filed for Approval
Cellulite
Potential Future Indications
Adhesive Capsulitis
Uterine Fibroids
Plantar Fibromatosis